Skip to main content

Client News

Convincing Overall Performance – Formycon Reports Preliminary Results for the Financial Year 2023 and Exceeds Forecast

15th April 2024

Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World

11th April 2024

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium

11th April 2024

Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technolog

11th April 2024

CARBIOS Announces Fiscal-Year 2023 Financial Results and Confirms 2024 Calendar for Industrial and Commercial Roll-Out

11th April 2024

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

10th April 2024

CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth

10th April 2024

ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa

10th April 2024

Mainz Biomed Reports Full Year 2023 Financial Results

9th April 2024

G.ST Antivirals Reports Start of Phase II Trial and Announces Appointment of Ronald Bruce Turner as New Chief Medical Officer

9th April 2024